Filtered By:
Infectious Disease: COVID-19
Vaccination: Cancer Vaccines
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 1918 results found since Jan 2013.
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer
CONCLUSION: Our findings highlight a consistent reduction of COVID-19 severity in patients with breast cancer during the Omicron outbreak in Europe. We also demonstrate that even in this population, a complete severe acute respiratory syndrome coronavirus 2 vaccination course is a strong determinant of improved morbidity and mortality from COVID-19.PMID:36720089 | DOI:10.1200/JCO.22.01667
Source: Clinical Breast Cancer - January 31, 2023 Category: Cancer & Oncology Authors: Marco Tagliamento Alessandra Gennari Matteo Lambertini Ramon Salazar Nadia Harbeck Lucia Del Mastro Juan Aguilar-Company Mark Bower Rachel Sharkey Alessia Dalla Pria Andrea Plaja Amanda Jackson Jasmine Handford Ailsa Sita-Lumsden Clara Martinez-Vila Marta Source Type: research
The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti-Cancer Treatment
CONCLUSION: This is the largest on-going longitudinal real-world dataset of patients undergoing ACT during the early stages of the COVID-19 pandemic. This preliminary analysis demonstrates that patients with solid tumors undergoing ACT have high protection from SARS-CoV-2 infection following COVID-19 vaccination. The SCCAMP study will evaluate long-term COVID-19 antibody trends, focusing on specific ACTs and patient subgroups.PMID:36719033 | DOI:10.1093/oncolo/oyac257
Source: The Oncologist - January 31, 2023 Category: Cancer & Oncology Authors: Karin Purshouse John P Thomson Mah éva Vallet Lorna Alexander Isaac Bonisteel Maree Brennan David A Cameron Jonine D Figueroa Elizabeth Furrie Pamela Haig Mattea Heck Hugh McCaughan Paul Mitchell Heather McVicars Lorraine Primrose Ines Silva Kate Templet Source Type: research
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer
CONCLUSION: Our findings highlight a consistent reduction of COVID-19 severity in patients with breast cancer during the Omicron outbreak in Europe. We also demonstrate that even in this population, a complete severe acute respiratory syndrome coronavirus 2 vaccination course is a strong determinant of improved morbidity and mortality from COVID-19.PMID:36720089 | DOI:10.1200/JCO.22.01667
Source: Clinical Genitourinary Cancer - January 31, 2023 Category: Cancer & Oncology Authors: Marco Tagliamento Alessandra Gennari Matteo Lambertini Ramon Salazar Nadia Harbeck Lucia Del Mastro Juan Aguilar-Company Mark Bower Rachel Sharkey Alessia Dalla Pria Andrea Plaja Amanda Jackson Jasmine Handford Ailsa Sita-Lumsden Clara Martinez-Vila Marta Source Type: research
Potential health risks of mRNA-based vaccine therapy: a hypothesis
Med Hypotheses. 2023 Jan 25:111015. doi: 10.1016/j.mehy.2023.111015. Online ahead of print.ABSTRACTTherapeutic applications of synthetic mRNA were proposed more than 30 years ago, and are currently the basis of one of the vaccine platforms used at a massive scale as part of the public health strategy to get COVID-19 under control. To date, there are no published studies on the biodistribution, cellular uptake, endosomal escape, translation rates, functional half-life and inactivation kinetics of synthetic mRNA, rates and duration of vaccine-induced antigen expression in different cell types. Furthermore, despite the assump...
Source: Cancer Control - January 31, 2023 Category: Cancer & Oncology Authors: K Acevedo-Whitehouse R Bruno Source Type: research
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer
CONCLUSION: Our findings highlight a consistent reduction of COVID-19 severity in patients with breast cancer during the Omicron outbreak in Europe. We also demonstrate that even in this population, a complete severe acute respiratory syndrome coronavirus 2 vaccination course is a strong determinant of improved morbidity and mortality from COVID-19.PMID:36720089 | DOI:10.1200/JCO.22.01667
Source: Clinical Genitourinary Cancer - January 31, 2023 Category: Cancer & Oncology Authors: Marco Tagliamento Alessandra Gennari Matteo Lambertini Ramon Salazar Nadia Harbeck Lucia Del Mastro Juan Aguilar-Company Mark Bower Rachel Sharkey Alessia Dalla Pria Andrea Plaja Amanda Jackson Jasmine Handford Ailsa Sita-Lumsden Clara Martinez-Vila Marta Source Type: research
Epidemiological study on the impact of influenza vaccination on the clinical course of patients with COVID-19 and co-infection by both viruses in Gran Canaria, Spain
CONCLUSIONS: Old age, male sex and cancer were independent prognostic factors for mortality. Three doses of SARS-CoV-2 vaccines and influenza vaccines were highly effective in preventing COVID-19-related deaths and hospital admissions. These findings suggest that flu vaccination can help control the pandemic.PMID:36709415 | DOI:10.37201/req/102.2022
Source: Revista Espanola de Quimioterapia - January 29, 2023 Category: Drugs & Pharmacology Authors: J L Alonso Bilbao A de Arriba Fern ández A Espi ñeira Francés A Cabeza Mora A Guti érrez Pérez M A D íaz Barreiros Source Type: research
The case of T-ALL presenting with NK phenotype after COVID-19 vaccination
We present a 55-year-old man who had cervical lymph node swelling post vaccination for COVID-19. Hematological malignancy was suspected due to the presence of atypical lymphoid cells with an elevated IL-2R in laboratory data. Tumor cells were positive for CD7, CD56, cyCD3, and terminal deoxynucleotidyl transferase (TdT) evidenced through flow cytometry of the bone marrow and the lymph node. The histopathological findings showed monotonous tumor cell proliferation, the cells being positive for CD3 and TdT in the bone marrow and they were positive for CD3, TdT, and CD56 in lymph node. Even though these findings suggested NK-...
Source: Cell Research - January 27, 2023 Category: Cytology Authors: Eriko Yanagida Akira Kubota Hiroaki Miyoshi Koichi Ohshima Toshiro Kawakita Toshihiko Murayama Source Type: research
Reply to: COVID-19 Vaccination in Patients who Develop COVID-19 After Cancer Surgery: Correspondence by Mungmunpuntipantip and Wiwanitkit
Ann Surg Oncol. 2023 Jan 27. doi: 10.1245/s10434-022-13087-7. Online ahead of print.NO ABSTRACTPMID:36707483 | DOI:10.1245/s10434-022-13087-7
Source: Ann Oncol - January 27, 2023 Category: Cancer & Oncology Authors: Nathaniel B Verhagen Anai N Kothari Source Type: research
